← Back to all trials
Active Not Recruiting
NCT07106021
A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's Disease
Conditions: Idiopathic Parkinson´s Disease, Parkinson's Disease
Sex: All
Ages: 45 Years – 75 Years
Healthy volunteers: No
Phase: PHASE1, PHASE2
Enrollment: 12
Sponsor: Kenai Therapeutics
Location: University of Arizona Tucson Arizona
Summary
This clinical trial is designed to test the safety and tolerability of the study intervention, RNDP-001, which will be implanted into the brain of study participants during a surgical procedure.
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of idiopathic Parkinson's disease consistent with the Movement Disorders Society Clinical Criteria
* Age 45 to 75
* Medically stable to undergo a surgical procedure
Exclusion Criteria:
* Known Parkinson's disease gene mutation or variant
* Previous infusion therapy or surgery for Parkinson's disease
* History of allergic reaction or intolerance to an immunotherapeutic agent
* Contraindication to MRI
* Clinically significant medical conditions likely to interfere with the surgical procedure or study assessments
Source: ClinicalTrials.gov (NCT07106021). StuddyBuddy aggregates publicly available trial information.
